Source:http://linkedlifedata.com/resource/pubmed/id/18359400
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
2
|
pubmed:dateCreated |
2008-3-24
|
pubmed:abstractText |
Minimally invasive therapies for urolithiasis including extracorporeal shock wave lithotripsy, ureteroscopy, and percutaneous nephrostolithotomy are highly efficacious, yet expensive. Medical expulsive therapy offers a cost-effective, nonsurgical approach for appropriate patients with ureteral stones. The use of hormones, nonsteroidal anti-inflammatories, calcium channel blockers, corticosteroids, and adrenergic alpha antagonists all have been proposed as a way to enhance stone passage. In view of the available clinical trials and meta-analysis, patients with distal ureteral stones measuring 1 cm who are candidates for observation deserve a trial of medical expulsive therapy. Nifedipine, a calcium channel blocker, and adrenergic alpha antagonists have been proven to be clinically efficacious, safe, and well tolerated as medical expulsive agents.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Mar
|
pubmed:issn |
0270-9295
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
28
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
192-9
|
pubmed:meshHeading | |
pubmed:year |
2008
|
pubmed:articleTitle |
Medical expulsive therapy.
|
pubmed:affiliation |
Division of Urology, University of Wisconsin, Madison, WI, USA.
|
pubmed:publicationType |
Journal Article,
Review
|